Search results for "Eliglustat tartrate"

showing 1 items of 1 documents

HGG-03. THE GLYCOSPHINGOLIPIDS METABOLISM IS A NOVEL TARGET IN H3K27M-MUTANT DIFFUSE MIDLINE GLIOMA

2021

Abstract H3K27M-mutant diffuse midline glioma (H3K27M-mutant DMG) is a rare malignant brain tumour entity in children and adults with a median overall survival of around 12 months. Genomic and proteomic analysis may help to identify new target structures, however not all relevant targets are covered by these analyses. Glycosphingolipids and particularly gangliosides play a major role in brain development and have been involved in the pathology of brain tumours. The conversion of ceramide to glucosylceramide via glucosylceramide synthase (GCS) is one of the first steps in the synthesis of glycosphingolipids. Therefore, targeting GCS will inhibit their synthesis. Here we analysed the glycosph…

Cancer ResearchMutationBrain developmentmedicine.diagnostic_testChemistryCell growthMutantMetabolismEliglustat tartratemedicine.diseasemedicine.disease_causeFlow cytometryOncologyGliomamedicineCancer researchAcademicSubjects/MED00300AcademicSubjects/MED00310High Grade GliomasNeurology (clinical)Neuro-Oncology
researchProduct